Loading…

Orbia Advance Corporation's Fluor & Energy Materials business is advancing construction of a larger-scale medical propellant purification plant at its Rocksavage site in Runcorn, UK, to increase production capacity for Zephex 152a (HFA 152a), a low-GWP propellant for metered-dose inhalers. Capacity readiness is targeted for mid-2026.
“This plant is a strategic capital investment intended to secure global supply of our low-GWP Zephex 152a and plays an important role in enabling our customers to achieve their climate goals.”businesswire.com
Summarized from public sources; check the original articles before acting on it.